Back to User profile » Dr Genki Sato
Papers published by Dr Genki Sato:
Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study
Itsukaichi A, Yoshikawa F, Fuchigami A, Iwata Y, Sato G, Miyagi M, Hirose T, Uchino H
Diabetes, Metabolic Syndrome and Obesity 2025, 18:101-111
Published Date: 9 January 2025
Glucose Tolerance and the Risk Factors for Transmission in Japanese SARS-CoV-2/WA-1/2020 Epicenter: A Retrospective Study
Saito M, Uchino H, Iwata Y, Fuchigami A, Sato G, Yoshikawa F, Miyagi M, Miyazaki T, Urita Y, Aoki K, Ishii Y, Tateda K, Hirose T
Diabetes, Metabolic Syndrome and Obesity 2024, 17:2547-2554
Published Date: 20 June 2024
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
Hisanaga K, Uchino H, Kakisu N, Miyagi M, Yoshikawa F, Sato G, Isobe K, Kishi K, Homma S, Hirose T
Diabetes, Metabolic Syndrome and Obesity 2021, 14:3109-3110
Published Date: 6 July 2021
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
Hisanaga K, Uchino H, Kakisu N, Miyagi M, Yoshikawa F, Sato G, Isobe K, Kishi K, Homma S, Hirose T
Diabetes, Metabolic Syndrome and Obesity 2021, 14:773-781
Published Date: 22 February 2021